Home Newsfeeds UBS Maintains Neutral on General Mills, Lowers Price Target to $85

UBS Maintains Neutral on General Mills, Lowers Price Target to $85

UBS analyst Cody Ross maintains General Mills (NYSE:GIS) with a Neutral and lowers the price target from $88 to $85.

byBenzinga Newsdesk

December 21, 2022

1 minute read

UBS analyst Cody Ross maintains General Mills (NYSE:GIS) with a Neutral and lowers the price target from $88 to $85.

Stifel Upgrades Verve Therapeutics to Buy, Raises Price Target to $56

By Benzinga Newsdesk

August 25, 5:02 AM

Stifel analyst Dae Gon Ha upgrades Verve Therapeutics (NASDAQ:VERV) from Hold to Buy and raises the price target from $32 to $56.

VERV

AIG Stock Dips Following Q4 Results

By Erica Kollmann

February 13, 6:11 PM

AIG reported quarterly earnings of $1.79 per share which beat the analyst consensus estimate of $1.64 by 9.15%. The company reported fourth-quarter net premium written of $5.61 billion, an increase of 3% year-over-year.

AIG

Devon Energy Eyes Marathon Oil, Weighs Strategic Acquisitions To Boost US Shale Presence

By Vandana Singh

October 19, 8:49 AM

Oil and gas player Devon Energy Corp (NYSE: DVN) is reportedly exploring potential acquisition opportunities to bolster its presence in the U.S.

CHK

Nextracker Inks Multi-Year Agreement To Supply Strata Solar Power Projects

By Shivani Kumaresan

March 29, 5:31 AM

Nextracker Inc (NASDAQ:NXT) has signed a multi-year volume commitment agreement with Strata Clean Energy to supply trackers. The financial terms were not disclosed.…

NXT

UBS Maintains Neutral on General Mills, Lowers Price Target to $85

Related Posts

Stifel Upgrades Verve Therapeutics to Buy, Raises Price Target to $56

AIG Stock Dips Following Q4 Results

Devon Energy Eyes Marathon Oil, Weighs Strategic Acquisitions To Boost US Shale Presence

Nextracker Inks Multi-Year Agreement To Supply Strata Solar Power Projects